Institutional Ownership Revolution Medicines, Inc. (RVMD)
This table provides information about the institutional ownership of Revolution Medicines, Inc. (RVMD). We have compiled data on the 357 institutions that hold shares in the stock, with a total of 195 Million shares, which have been reported (via 13F filing form) to have a value of $13.2 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
15,663,094
shares
|
$1.06 Billion
0.01% of portfolio
|
Q3 2025
Reduced 0.63%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
14,625,692
shares
|
$991 Million
2.96% of portfolio
|
Q3 2025
Added 2.09%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,408,713
shares
|
$908 Million
0.01% of portfolio
|
Q2 2024
Added 8.94%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
11,356,054
shares
|
$769 Million
0.26% of portfolio
|
Q3 2025
Added 7.23%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2025 Q3 2025 |
9,813,436
shares
|
$665 Million
0.08% of portfolio
|
Q3 2025
Reduced 4.35%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
9,455,357
shares
|
$641 Million
3.6% of portfolio
|
Q3 2025
Added 0.97%
|
|
|
Nextech Invest Ag
|
Feb 14, 2025 Q4 2024 |
7,601,087
shares
|
$515 Million
61.97% of portfolio
|
Q4 2024
Added 20.71%
|
|
|
Nextech Invest, Ltd.
Zurich, V8 |
Nov 14, 2025 Q3 2025 |
7,601,087
shares
|
$515 Million
54.03% of portfolio
|
Q1 2025
New holding
|
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Nov 14, 2025 Q3 2025 |
6,223,291
shares
|
$422 Million
9.36% of portfolio
|
Q3 2025
Added 2.13%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Nov 14, 2025 Q3 2025 |
5,573,838
shares
|
$378 Million
5.57% of portfolio
|
Q3 2025
Added 21.72%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
5,254,639
shares
|
$356 Million
0.01% of portfolio
|
Q3 2025
Added 11.35%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
4,782,318
shares
|
$324 Million
0.14% of portfolio
|
Q3 2025
Added 1.98%
|
|
|
Alphabet Inc.
Mountain View, CA |
Nov 06, 2025 Q3 2025 |
4,133,277
shares
|
$280 Million
11.43% of portfolio
|
Q4 2024
Reduced 2.89%
|
|
|
Bvf Inc
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
3,974,913
shares
|
$269 Million
10.04% of portfolio
|
Q3 2025
Reduced 20.22%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
3,873,706
shares
|
$262 Million
0.02% of portfolio
|
Q3 2025
Reduced 17.62%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2025 Q3 2025 |
3,650,342
shares
|
$247 Million
3.17% of portfolio
|
Q3 2025
Added 7.87%
|
|
|
Holocene Advisors, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
3,437,283
shares
|
$233 Million
0.39% of portfolio
|
Q3 2025
Reduced 5.39%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
3,145,640
shares
|
$213 Million
0.01% of portfolio
|
Q3 2025
Added 5.07%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2025 Q3 2025 |
2,915,883
shares
|
$198 Million
0.7% of portfolio
|
Q3 2025
Added 0.01%
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
2,647,333
shares
|
$179 Million
16.85% of portfolio
|
Q3 2025
Reduced 8.33%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
Nov 10, 2025 Q3 2025 |
2,513,967
shares
|
$170 Million
0.54% of portfolio
|
Q3 2025
Added 136.26%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
2,498,327
shares
|
$169 Million
0.01% of portfolio
|
Q3 2025
Reduced 32.53%
|
|
|
General Atlantic LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
2,474,428
shares
|
$168 Million
4.09% of portfolio
|
Q3 2025
New holding
|
|
|
Lunate Capital LTD
Al Maryah Island, Abu Dhabi, C0 |
Nov 10, 2025 Q3 2025 |
2,196,200
shares
|
$149 Million
8.56% of portfolio
|
Q1 2025
New holding
|
|
|
Lunate Holding Rsc LTD
Al Maryah Island, Abu Dhabi, C0 |
Feb 14, 2025 Q4 2024 |
2,196,200
shares
|
$149 Million
45.54% of portfolio
|
Q4 2024
New holding
|
|